Section 3014 of the Patient Protection
and Affordable Care Act (ACA, 2010) (P.L. 111-148) (ACA) requires
that the Secretary of the Department of Health and Human Services
(HHS) conduct an assessment of the quality and efficiency impact of
the use of endorsed measures in specific Medicare quality reporting
and incentive programs. The ACA further specifies that the initial
assessment must occur no later than March 1, 2012, and once every 3
years thereafter. This planned data collection activity was
developed and tested as part of the 2015 Impact Report and data
collection will be conducted for reporting in the 2018 Impact
Report. The implementation of quality measures by CMS has led to
positive gains in the use of evidence-based standards of care by
providers. To ensure the nation continues to build on these gains,
and to fulfill the requirements of Section 3014 of the Patient
Protection and Affordable Care Act of 2010 (ACA) for the assessment
of the quality and efficiency impact of the use of endorsed
measures in specific Medicare quality reporting and incentive
programs, CMS has conducted two national impact assessments (first
assessment reported in 2012 and the second to be reported in
2015.).
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.